Antibodies That Bind To OX40 and Their Uses
US-2020071409-A1 · Mar 5, 2020 · US
This page is not indexed by search engines while we improve data quality.
Glenmark Pharmaceuticals Sa — Physics
Glenmark Pharmaceuticals Sa holds 10 patents in Physics, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Glenmark Pharmaceuticals Sa |
| Technology | Physics |
| Patents in slice | 10 |
| Recent patents in slice | 0 |
| First year | 2016 |
| Last year | 2020 |
Representative patents
Notable publications linking Glenmark Pharmaceuticals Sa to Physics.
Polymorphs of a mPGES-1 inhibiting triazolone compound
US-10457649-B2 · Oct 29, 2019 · US
Polymorphs of a mPGES-1 inhibiting triazolone compound
US-10457649-B2 · Oct 29, 2019 · US
Expression constructs and methods for selecting host cells expressing polypeptides
US-2019056396-A1 · Feb 21, 2019 · US
Expression constructs and methods for selecting host cells expressing polypeptides
US-2019056396-A1 · Feb 21, 2019 · US
Recent filings
Latest patents from Glenmark Pharmaceuticals Sa in Physics.
Antibodies That Bind To OX40 and Their Uses
US-2020071409-A1 · Mar 5, 2020 · US
Polymorphs of a mPGES-1 inhibiting triazolone compound
US-10457649-B2 · Oct 29, 2019 · US
Polymorphs of a mPGES-1 inhibiting triazolone compound
US-10457649-B2 · Oct 29, 2019 · US
Expression constructs and methods for selecting host cells expressing polypeptides
US-2019056396-A1 · Feb 21, 2019 · US
Expression constructs and methods for selecting host cells expressing polypeptides
US-2019056396-A1 · Feb 21, 2019 · US
Related pages
Navigate to parent entity pages.